|
|
||||||||
Journal of Lipid Research, Vol 30, 1621-1632, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
RT Fischer, SH Stam, PR Johnson, SS Ko, RL Magolda, JL Gaylor and JM Trzaskos
Medical Products Department, E.I. du Pont de Nemours and Co., Wilmington, DE 19880-0400.
Lanosterol 14 alpha-methyl demethylation is a cytochrome P-450- dependent process that proceeds through the oxidative sequence of alcohol, aldehyde followed by decarbonylation with formic acid release. Microsomal metabolism studies shown here indicate that only lanostenols and 32-oxy-lanostenols with unsaturation at either the delta 7 or delta 8 position in the sterol can be demethylated. The 14 alpha-methyl group of either lanostan-3 beta-ol or delta 6 lanostenol is not oxidized to the anticipated C-32 alcohol or aldehyde by the enzyme, nor are the corresponding 32-oxy-lanostanols demethylated when incubated with microsomal preparations. Despite the lack of metabolism, the saturated and delta 6 sterol analogues are effective competitive inhibitors of demethylase activity. Utilizing preferred substrates, comparison of the component reactions of the demethylation sequence shows that both the oxidative function and lyase function are sensitive to common inhibitors and that both activities require NADPH. These findings strongly support the premise that a P-450 isozyme does catalyze each phase of the lanosterol 14 alpha-methyl demethylation sequence. Collectively these results demonstrate the double-bond requirement for both components of the demethylation sequence and suggest that the olefinic electrons at delta 7 or delta 8 but not delta 6 may participate directly during demethylation. This participation may involve stabilizing a transition state intermediate or directing activated oxygen insertion as part of the P-450 monoxygenase mechanism.
This article has been cited by other articles:
![]() |
S. Saikia, E. J. Parker, A. Koulman, and B. Scott Defining Paxilline Biosynthesis in Penicillium paxilli: FUNCTIONAL CHARACTERIZATION OF TWO CYTOCHROME P450 MONOOXYGENASES J. Biol. Chem., June 8, 2007; 282(23): 16829 - 16837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Pietila, P. K. Vohra, B. Sanyal, N. L. Wengenack, S. Raghavakaimal, and C. F. Thomas Jr. Cloning and Characterization of CYP51 from Mycobacterium avium Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 236 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuura, S. Yoshioka, T. Tosha, H. Hori, K. Ishimori, T. Kitagawa, I. Morishima, N. Kagawa, and M. R. Waterman Structural Diversities of Active Site in Clinical Azole-bound Forms between Sterol 14{alpha}-Demethylases (CYP51s) from Human and Mycobacterium tuberculosis J. Biol. Chem., March 11, 2005; 280(10): 9088 - 9096. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bellamine, G. I. Lepesheva, and M. R. Waterman Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology J. Lipid Res., November 1, 2004; 45(11): 2000 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bellamine, A. T. Mangla, A. L. Dennis, W. D. Nes, and M. R. Waterman Structural requirements for substrate recognition of Mycobacterium tuberculosis 14{{alpha}}-demethylase: implications for sterol biosynthesis J. Lipid Res., January 1, 2001; 42(1): 128 - 136. [Abstract] [Full Text] |
||||
![]() |
A. Bellamine, A. T. Mangla, W. D. Nes, and M. R. Waterman Characterization and catalytic properties of the sterol 14alpha -demethylase from Mycobacterium tuberculosis PNAS, August 3, 1999; 96(16): 8937 - 8942. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Johnson, R. T. Fischer, M. C. Phillips, and G. H. Rothblat Efflux of Newly Synthesized Cholesterol and Biosynthetic Sterol Intermediates from Cells J. Biol. Chem., October 20, 1995; 270(42): 25037 - 25046. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Lepesheva, L. M. Podust, A. Bellamine, and M. R. Waterman Folding Requirements Are Different between Sterol 14alpha -Demethylase (CYP51) from Mycobacterium tuberculosis and Human or Fungal Orthologs J. Biol. Chem., July 20, 2001; 276(30): 28413 - 28420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |